Trecadrine

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameTrecadrine
Drug Alias NameWAS-4304WAS-4351
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-3 adrenergic receptor agonistsGastrins inhibitors
TargetsGastrinsBeta-3 adrenergic receptor
Therapy Area/IndicationsObesityDiabetes MellitusPeptic Ulcer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWasserman-Seeft
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWasserman-Seeft
Active IndicationsN/A
Inactive IndicationsObesityDiabetes MellitusPeptic Ulcer

Other Information

ATC CodeN/A
Related LinksN/A